Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Interference in the anti-Xa heparin activity assay due to hemolysis and icterus during pediatric extracorporeal life support.

Khan J, Chandler WL.

Artif Organs. 2019 Sep;43(9):880-887. doi: 10.1111/aor.13467. Epub 2019 May 16.

PMID:
30964951
2.

External Quality Assurance of Platelet Function Assays: Results of the College of American Pathologists Proficiency Testing Program.

Chandler WL, Brown AF, Chen D, Moser K, Olson JD, Pham HP, Smock KJ, Volod O, Higgins RA.

Arch Pathol Lab Med. 2019 Apr;143(4):472-482. doi: 10.5858/arpa.2017-0556-CP. Epub 2018 Dec 21.

PMID:
30920864
3.

Monitoring Hemostasis During Extracorporeal Life Support.

Saifee NH, Brogan TV, McMullan DM, Yalon L, Matthews DC, Burke CR, Chandler WL.

ASAIO J. 2019 Mar 21. doi: 10.1097/MAT.0000000000000993. [Epub ahead of print]

PMID:
30913107
4.

Discordant Partial Thromboplastin Time (PTT) vs Anti-Xa Heparin Activity.

Khan J, Chandler WL.

Am J Clin Pathol. 2019 Mar 1;151(4):424-432. doi: 10.1093/ajcp/aqy156.

PMID:
30475952
5.

Issues Surrounding Age-Adjusted d-Dimer Cutoffs That Practicing Physicians Need to Know When Evaluating Patients With Suspected Pulmonary Embolism.

Goodwin AJ, Higgins RA, Moser KA, Smock KJ, Chandler WL, Kottke-Marchant K, Hartman SK, Volod O, Brown AF, Johari VP, Burr S, Polyakov N, Chen D.

Ann Intern Med. 2017 Mar 7;166(5):361-363. doi: 10.7326/M16-2030. Epub 2016 Dec 27. No abstract available. Erratum in: Ann Intern Med. 2018 Jul 17;169(2):136.

PMID:
28024301
6.

Measurement of microvesicle levels in human blood using flow cytometry.

Chandler WL.

Cytometry B Clin Cytom. 2016 Jul;90(4):326-36. doi: 10.1002/cyto.b.21343. Epub 2016 Feb 3. Review.

7.

Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method.

Chen J, Phillips B, Chandler WL.

Blood Coagul Fibrinolysis. 2016 Jan;27(1):90-6. doi: 10.1097/MBC.0000000000000375.

PMID:
26397883
8.

In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices.

Girdhar G, Li J, Kostousov L, Wainwright J, Chandler WL.

J Thromb Thrombolysis. 2015 Nov;40(4):437-43. doi: 10.1007/s11239-015-1228-0.

PMID:
25975924
9.

Evaluation and Pharmacokinetics of Treatment Dose Enoxaparin in Hospitalized Patients With Morbid Obesity.

Thompson-Moore NR, Wanat MA, Putney DR, Liebl PH, Chandler WL, Muntz JE.

Clin Appl Thromb Hemost. 2015 Sep;21(6):513-20. doi: 10.1177/1076029614568713. Epub 2015 Jan 19.

PMID:
25601898
10.

Patients with cirrhosis show a relative increase in thrombin generation that is correlated with lower antithrombin levels.

Chandler WL, Dawson KL, Ruegger MC, Teruya M, Liebl PH, Monsour HP.

Blood Coagul Fibrinolysis. 2014 Nov 14. [Epub ahead of print]

PMID:
25402190
11.

Platelet function assays--not all are created equal.

Chandler WL.

Clin Chem. 2014 Dec;60(12):1469-70. doi: 10.1373/clinchem.2014.233130. Epub 2014 Oct 20. No abstract available.

12.

Platelet mapping assay interference due to platelet activation in heparinized samples.

Nelles NJ, Chandler WL.

Am J Clin Pathol. 2014 Sep;142(3):331-8. doi: 10.1309/AJCPQ9BYJ0OEENGA.

PMID:
25125623
13.

Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.

Shu I, Wright AM, Chandler WL, Bernard DW, Wang P.

Ther Drug Monit. 2014 Apr;36(2):264-8. doi: 10.1097/FTD.0b013e3182a3b3f6.

PMID:
24232125
14.

Anticoagulation without monitoring.

Chandler WL.

Am J Clin Pathol. 2013 Nov;140(5):606-7. doi: 10.1309/AJCPE8CWKOVG4AGX. No abstract available.

PMID:
24124137
15.

Emergency assessment of hemostasis in the bleeding patient.

Chandler WL.

Int J Lab Hematol. 2013 Jun;35(3):339-43. doi: 10.1111/ijlh.12071. Epub 2013 Mar 11. Review.

PMID:
23480055
16.

Circulating microparticles in neuropsychiatric systemic lupus erythematosus.

Crookston KP, Sibbitt WL Jr, Chandler WL, Qualls CR, Roldan CA.

Int J Rheum Dis. 2013 Feb;16(1):72-80. doi: 10.1111/1756-185x.12026. Epub 2013 Jan 18.

PMID:
23441775
17.

Microparticle counts in platelet-rich and platelet-free plasma, effect of centrifugation and sample-processing protocols.

Chandler WL.

Blood Coagul Fibrinolysis. 2013 Mar;24(2):125-32. doi: 10.1097/MBC.0b013e32835a0824.

PMID:
23249614
18.

Bleeding risks and response to therapy in patients with INR higher than 9.

Pagano MB, Chandler WL.

Am J Clin Pathol. 2012 Oct;138(4):546-50.

PMID:
23010709
19.

External quality assurance of fibrinogen assays using normal plasma: results of the 2008 College of American Pathologists proficiency testing program in coagulation.

Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD.

Arch Pathol Lab Med. 2012 Jul;136(7):789-95. doi: 10.5858/arpa.2011-0322-OA.

PMID:
22742551
20.

Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.

Avecilla ST, Ferrell C, Chandler WL, Reyes M.

Am J Clin Pathol. 2012 Apr;137(4):572-4. doi: 10.1309/AJCPAU7OQM0SRPZQ.

PMID:
22431533
21.

Should all adult patients with diarrhoea-associated HUS receive plasma exchange?

Tarr PI, Sadler JE, Chandler WL, George JN, Tsai HM.

Lancet. 2012 Feb 11;379(9815):516; author reply 516-7. doi: 10.1016/S0140-6736(12)60225-6. No abstract available.

PMID:
22325653
22.

comparison of clot-based vs chromogenic factor Xa procoagulant phospholipid activity assays.

Bohling SD, Pagano MB, Stitzel MR, Ferrell C, Yeung W, Chandler WL.

Am J Clin Pathol. 2012 Feb;137(2):185-92. doi: 10.1309/AJCPGSJ4NHFQMX9W.

PMID:
22261442
23.

Activation of the hemostatic system during cardiopulmonary bypass.

Sniecinski RM, Chandler WL.

Anesth Analg. 2011 Dec;113(6):1319-33. doi: 10.1213/ANE.0b013e3182354b7e. Epub 2011 Oct 14. Review.

PMID:
22003219
24.

Reducing the use of coagulation test panels.

Amukele TK, Baird GS, Chandler WL.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):688-95. doi: 10.1097/MBC.0b013e32834b8246.

PMID:
21934488
25.

Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience.

Chandler WL, Peerschke EI, Castellone DD, Meijer P; NASCOLA Proficiency Testing Committee.

Am J Clin Pathol. 2011 Jun;135(6):862-9. doi: 10.1309/AJCPH5JK4ONENPAE.

PMID:
21571959
26.

A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer.

Chandler WL, Yeung W, Tait JF.

J Thromb Haemost. 2011 Jun;9(6):1216-24. doi: 10.1111/j.1538-7836.2011.04283.x.

27.

External quality assurance of antithrombin, protein C, and protein s assays: results of the College of American Pathologists proficiency testing program in thrombophilia.

Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD.

Arch Pathol Lab Med. 2011 Feb;135(2):227-32. doi: 10.1043/1543-2165-135.2.227.

PMID:
21284443
28.

Development of a rapid emergency hemorrhage panel.

Chandler WL, Ferrell C, Trimble S, Moody S.

Transfusion. 2010 Dec;50(12):2547-52. doi: 10.1111/j.1537-2995.2010.02753.x.

PMID:
20573070
29.

Procoagulant activity in trauma patients.

Chandler WL.

Am J Clin Pathol. 2010 Jul;134(1):90-6. doi: 10.1309/AJCP3WPOYSKK6BFE.

PMID:
20551272
30.

Comparison of plasma with whole blood prothrombin time and fibrinogen on the same instrument.

Amukele TK, Ferrell C, Chandler WL.

Am J Clin Pathol. 2010 Apr;133(4):550-6. doi: 10.1309/AJCPLDT9OVX1TDGT.

PMID:
20231607
31.

Thrombin generation and plasma dilution.

Hemker HC, De Smedt E, Chandler WL, Roshal M.

Am J Clin Pathol. 2010 Jan;133(1):163; author reply 164. doi: 10.1309/AJCPX63EFKZSYOQI. No abstract available.

PMID:
20023273
32.

The Response of Hemostatic Marker Levels to Activated Factor VII in a Neonate following Cardiopulmonary Bypass.

Eisses MJ, Richards M, Joffe D, Geiduschek JM, Chandler WL.

Case Rep Med. 2009;2009:420152. doi: 10.1155/2009/420152. Epub 2009 Aug 31.

33.

Thrombin generation in trauma patients.

Dunbar NM, Chandler WL.

Transfusion. 2009 Dec;49(12):2652-60. doi: 10.1111/j.1537-2995.2009.02335.x. Epub 2009 Aug 4.

PMID:
19682336
34.

Optimization of plasma fluorogenic thrombin-generation assays.

Chandler WL, Roshal M.

Am J Clin Pathol. 2009 Aug;132(2):169-79. doi: 10.1309/AJCP6AY4HTRAAJFQ.

PMID:
19605810
35.

Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.

Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, Chandler WL, Boyko EJ, Brunzell JD.

J Clin Endocrinol Metab. 2009 Apr;94(4):1104-10. doi: 10.1210/jc.2008-0701. Epub 2009 Jan 6.

36.

Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.

Eisses MJ, Chandler WL.

J Cardiothorac Vasc Anesth. 2008 Feb;22(1):53-9. doi: 10.1053/j.jvca.2007.06.006. Epub 2007 Aug 22.

PMID:
18249331
37.

Laboratory reporting of the international normalized ratio: progress and problems.

Olson JD, Brandt JT, Chandler WL, Van Cott EM, Cunningham MT, Hayes TE, Kottke-Marchant KK, Makar RS, Uy AB, Wang EC.

Arch Pathol Lab Med. 2007 Nov;131(11):1641-7.

PMID:
17979481
38.

Does the type of surgery effect systemic response following cardiopulmonary bypass?

Takayama H, Soltow LO, Chandler WL, Vocelka CR, Aldea GS.

J Card Surg. 2007 Jul-Aug;22(4):307-13.

PMID:
17661772
39.

Monitoring direct thrombin inhibitors with a plasma diluted thrombin time.

Love JE, Ferrell C, Chandler WL.

Thromb Haemost. 2007 Jul;98(1):234-42.

PMID:
17598018
40.

Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program.

Cunningham MT, Brandt JT, Chandler WL, Eby CS, Hayes TE, Krishnan J, Lefkowitz JB, Olson JD, Stasik CJ, Teruya J, Van Cott EM.

Semin Thromb Hemost. 2007 Apr;33(3):250-8. Review.

PMID:
17427059
41.
42.

Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.

Eisses MJ, Geiduschek JM, Jonmarker C, Cohen GA, Chandler WL.

J Cardiothorac Vasc Anesth. 2007 Feb;21(1):28-34. Epub 2006 Jul 26.

PMID:
17289476
43.

A community study of the effect of particulate matter on blood measures of inflammation and thrombosis in an elderly population.

Sullivan JH, Hubbard R, Liu SL, Shepherd K, Trenga CA, Koenig JQ, Chandler WL, Kaufman JD.

Environ Health. 2007 Feb 1;6:3.

44.

Effect of fondaparinux on coagulation assays: results of College of American Pathologists proficiency testing.

Smogorzewska A, Brandt JT, Chandler WL, Cunningham MT, Hayes TE, Olson JD, Kottke-Marchant K, Van Cott EM.

Arch Pathol Lab Med. 2006 Nov;130(11):1605-11.

PMID:
17076521
45.

Coagulation factor VII gene haplotypes, obesity-related traits, and cardiovascular risk in young women.

Reiner AP, Carlson CS, Rieder MJ, Siscovick DS, Liu K, Chandler WL, Green D, Schwartz SM, Nickerson DA.

J Thromb Haemost. 2007 Jan;5(1):42-9. Epub 2006 Oct 16.

46.

Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma.

Yuan S, Ferrell C, Chandler WL.

Thromb Res. 2007;120(1):29-37. Epub 2006 Aug 2.

PMID:
16887171
47.

External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program.

Hayes TE, Brandt JT, Chandler WL, Eby CS, Kottke-Marchant K, Krishnan J, Lefkowitz JB, Olson JD, Rund CR, Van Cott EM, Cunningham MT.

Semin Thromb Hemost. 2006 Jul;32(5):499-504.

PMID:
16862523
48.

Antithrombin reduces monocyte and neutrophil CD11b up regulation in addition to blocking platelet activation during extracorporeal circulation.

Rinder CS, Rinder HM, Smith MJ, Fitch JC, Tracey JB, Chandler WL, Rollins SA, Smith BR.

Transfusion. 2006 Jul;46(7):1130-7.

PMID:
16836559
49.
50.

Supplemental Content

Loading ...
Support Center